Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Rifamycin M14
110
CHF
CHF 110.00
In stock
AG-CN2-0332-M01010 mgCHF 110.00
AG-CN2-0332-M05050 mgCHF 440.00
| Product Details | |
|---|---|
| Synonyms | Rifamide; NCI 143-418; NSC 143418; RF M-14; Rifampicin M/14; N,N-Diethylamide-rifamycin B; Rifomycin B diethylamide |
| Product Type | Chemical |
| Properties | |
| Formula |
C43H58N2O13 |
| MW | 810.9 |
| CAS | 2750-76-7 |
| Source/Host Chemicals | Semisynthetic. |
| Purity Chemicals | ≥95% (HPLC) |
| Appearance | Yellow to orange powder. |
| Solubility | Soluble in DMSO, aqueous acetonitrile or ethanol. |
| Identity | Determined by 1H-NMR and MS. |
| InChi Key | VFYNXKZVOUXHDX-XXQVUONBSA-N |
| Smiles | OC1=C(NC(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@H]([C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O2)OC)OC(C)=O)O)=O)C=C(OCC(N(CC)CC)=O)C3=C4C(O[C@@]2(C)C4=O)=C(C)C(O)=C31 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice |
Keep cool and dry. Protect from light. Protect from light when in solution. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Ansamycin antibiotic.
- Selective inhibitor of bacterial DNA-dependent RNA polymerase (RNAP).
- Effective against mycobacteria and therefore used in research of tuberculosis, leprosy and Mycobacterium avium complex (MAC) infections.
Product References
- In vitro bacteriological studies on rifamycin B diethylamide (rifamide): R. Pallanza, et al.; Arzneimittelforschung 15, 800 (1965)
- The inhibition of bacterial RNA synthesis by the rifamycin antibiotics: J.M. Wilhelm, et al.; Biochim. Biophys. Acta 166, 268 (1968)
- Rifamycins: A General View: S. Riva & L.G. Silvestri; Ann. Rev. Microbiol. 26, 199 (1972)
- Rifamycin antibiotics: inhibitors of Rauscher murine leukemia virus reverse transcriptase and of purified DNA polymerases from human normal and leukemic lymphoblasts: S.S. Yang, et al.; J. Natl. Cancer Inst. 49, 7 (1972)
- Rifamycin Derivatives Strongly Inhibiting RNA>DNA Polymerase (Reverse Transcriptase) of Murine Sarcoma Viruses: C. Gurgo, et al.; J. Natl. Cancer Inst. 49, 61 (1972)
- Inhibition of poly(A) polymerase by rifamycin derivatives: S.T. Jacob & K.M. Rose; Nucl. Acids Res. 1, 1549 (1974)
- Structure-Activity Relationships and DNA Polymerases From Normal and Specificity of Inhibition of Leukemia Cells of Man and From Simian Sarcoma Virus by Rifamycin Derivatives: R.A. CiCioccio & B.I.S. Srivastava; J. Natl. Cancer Inst. 61, 1187 (1978)
- Comparison of antibacterial and antiimmune effects of certain rifamycins: J.E. Kasik & M. Monick; Antimicrob. Agents Chemother. 19, 134 (1981)
- In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis: R.B. Jones, et al.; Rev. Infect. Dis. 5, S556 (1983)
- QSAR Modeling of Antimycobacterial Activity and Activity Against Other Bacteria of 3-Formyl Rifamycin SV Derivatives: D. Dimov, et al.; Quant. Struct.-Act. Relat. 20, 298 (2001)
Related Products
